Jenster G - Search Results

1

Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.

Böttcher R, Dulla K, van Strijp D, Dits N, Verhoef EI, Baillie GS, van Leenders GJ, Houslay MD, Jenster G, Hoffmann R. Böttcher R, et al. Among authors: jenster g. Oncotarget. 2016 Oct 25;7(43):70669-70684. doi: 10.18632/oncotarget.12204. Oncotarget. 2016. PMID: 27683107 Free PMC article.

2

Repression of androgen-regulated gene expression by dominant negative androgen receptors.

Bramlett KS, Dits NF, Sui X, Jorge MC, Zhu X, Jenster G. Bramlett KS, et al. Among authors: jenster g. Mol Cell Endocrinol. 2001 Oct 25;183(1-2):19-28. doi: 10.1016/s0303-7207(01)00636-0. Mol Cell Endocrinol. 2001. PMID: 11604220

3

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G. Hendriksen PJ, et al. Among authors: jenster g. Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082. Cancer Res. 2006. PMID: 16707422 Free article.

4

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.

Hermans KG, Bressers AA, van der Korput HA, Dits NF, Jenster G, Trapman J. Hermans KG, et al. Among authors: jenster g. Cancer Res. 2008 May 1;68(9):3094-8. doi: 10.1158/0008-5472.CAN-08-0198. Cancer Res. 2008. PMID: 18451133

5

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, Boormans JL, van der Kwast TH, van Dekken H, Bangma CH, Korsten H, Kraaij R, Jenster G, Trapman J. Hermans KG, et al. Among authors: jenster g. Cancer Res. 2008 Sep 15;68(18):7541-9. doi: 10.1158/0008-5472.CAN-07-5930. Cancer Res. 2008. PMID: 18794142

6

Gene expression of forkhead transcription factors in the normal and diseased human prostate.

van der Heul-Nieuwenhuijsen L, Dits NF, Jenster G. van der Heul-Nieuwenhuijsen L, et al. Among authors: jenster g. BJU Int. 2009 Jun;103(11):1574-80. doi: 10.1111/j.1464-410X.2009.08351.x. Epub 2009 Feb 11. BJU Int. 2009. PMID: 19220249

7

The FOXF2 pathway in the human prostate stroma.

van der Heul-Nieuwenhuijsen L, Dits N, Van Ijcken W, de Lange D, Jenster G. van der Heul-Nieuwenhuijsen L, et al. Among authors: jenster g. Prostate. 2009 Oct 1;69(14):1538-47. doi: 10.1002/pros.20996. Prostate. 2009. PMID: 19562724

8

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.

Hermans KG, Boormans JL, Gasi D, van Leenders GJ, Jenster G, Verhagen PC, Trapman J. Hermans KG, et al. Among authors: jenster g. Clin Cancer Res. 2009 Oct 15;15(20):6398-403. doi: 10.1158/1078-0432.CCR-09-1176. Epub 2009 Oct 13. Clin Cancer Res. 2009. PMID: 19825963

9

Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.

Hofland J, van Weerden WM, Dits NF, Steenbergen J, van Leenders GJ, Jenster G, Schröder FH, de Jong FH. Hofland J, et al. Among authors: jenster g. Cancer Res. 2010 Feb 1;70(3):1256-64. doi: 10.1158/0008-5472.CAN-09-2092. Epub 2010 Jan 19. Cancer Res. 2010. PMID: 20086173

10

Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Marques RB, Dits NF, Erkens-Schulze S, van Weerden WM, Jenster G. Marques RB, et al. Among authors: jenster g. PLoS One. 2010 Oct 19;5(10):e13500. doi: 10.1371/journal.pone.0013500. PLoS One. 2010. PMID: 20976069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters